Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Barclays
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $40k | 27k | 1.47 |
| 2025-06-30 | $1.6M | 1.3M | 1.29 |
| 2025-03-31 | $2.7M | 2.3M | 1.16 |
| 2024-12-31 | $2.1M | 1.9M | 1.07 |
| 2024-09-30 | $6.0M | 5.1M | 1.17 |
| 2024-06-30 | $1.7M | 1.6M | 1.08 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1